Kindly MD (KDLY) Competitors $1.17 -0.08 (-6.40%) As of 09/24/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KDLY vs. BMGL, CCM, MGRX, MRAI, BRTX, BGLC, ACON, DHAC, NIVF, and BACKShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Basel Medical Group (BMGL), Concord Medical Services (CCM), Mangoceuticals (MGRX), Marpai (MRAI), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry. Kindly MD vs. Its Competitors Basel Medical Group Concord Medical Services Mangoceuticals Marpai Biorestorative Therapies BioNexus Gene Lab Aclarion Digital Health Acquisition NewGenIvf Group IMAC Basel Medical Group (NASDAQ:BMGL) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. Does the media favor BMGL or KDLY? In the previous week, Basel Medical Group had 1 more articles in the media than Kindly MD. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for Kindly MD. Basel Medical Group's average media sentiment score of 1.89 beat Kindly MD's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media. Company Overall Sentiment Basel Medical Group Very Positive Kindly MD Neutral Is BMGL or KDLY more profitable? Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A Kindly MD N/A N/A N/A Which has stronger earnings and valuation, BMGL or KDLY? Basel Medical Group has higher earnings, but lower revenue than Kindly MD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/AKindly MD$2.47M2.85-$4.64M-$0.77-1.52 SummaryBasel Medical Group beats Kindly MD on 2 of the 3 factors compared between the two stocks. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KDLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLY vs. The Competition Export to ExcelMetricKindly MDHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.05M$59.36M$5.74B$10.39BDividend YieldN/AN/A5.75%4.64%P/E Ratio-1.52N/A75.8726.11Price / Sales2.851.74552.25124.93Price / CashN/A4.0237.5461.24Price / BookN/A1.1512.386.30Net Income-$4.64M-$30.80M$3.29B$271.03M7 Day Performance-21.48%-10.74%0.27%-0.14%1 Month Performance-87.24%-43.62%2.79%5.82%1 Year Performance3.08%3.08%60.41%27.63% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KDLYKindly MDN/A$1.17-6.4%N/A-4.9%$7.05M$2.47M-1.52N/AGap UpHigh Trading VolumeBMGLBasel Medical GroupN/A$1.78-0.6%N/AN/A$33.03MN/A0.0036CCMConcord Medical Services0.6891 of 5 stars$5.98-2.1%N/A-3.1%$26.53M$52.60M0.00970News CoverageMGRXMangoceuticals0.7605 of 5 stars$2.57+14.2%N/A-95.6%$23.71M$620K-0.673Positive NewsGap DownMRAIMarpaiN/A$1.05+2.5%N/A+104.5%$19.15M$34.87M-0.40150BRTXBiorestorative Therapies2.2946 of 5 stars$1.48+2.1%N/A-15.7%$11.57M$400K-1.177Positive NewsBGLCBioNexus Gene Lab0.6633 of 5 stars$5.49+2.2%N/A+41.6%$9.65M$9.51M0.0030Positive NewsACONAclarion2.6148 of 5 stars$8.89-5.4%$11,758.50+132,166.6%-99.5%$5.47M$50K0.007News CoverageGap DownHigh Trading VolumeDHACDigital Health AcquisitionN/A$0.64-3.1%N/A-57.8%$2.31MN/A0.002,021High Trading VolumeNIVFNewGenIvf GroupN/A$1.98+5.3%N/A-99.7%$1.63M$5.43M0.00N/APositive NewsBACKIMACN/A$0.07-5.6%N/A-94.0%$155K$72.05K0.00180News CoverageGap Down Related Companies and Tools Related Companies Basel Medical Group Alternatives Concord Medical Services Alternatives Mangoceuticals Alternatives Marpai Alternatives Biorestorative Therapies Alternatives BioNexus Gene Lab Alternatives Aclarion Alternatives Digital Health Acquisition Alternatives NewGenIvf Group Alternatives IMAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KDLY) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredMagnificent 7 being replaced by the “Secret 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.